Abbott Laboratories, US0028241000

Abbott Laboratories stock at EUR 95.30, down 1.02% premarket

Published on 11/18/2026 at 08:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott operates across medical devices, diagnostics, nutrition and established pharmaceuticals. On Xetra, the stock closed at EUR 96.28 on Tuesday, November 17, 2026.

Abbott's Healthcare Portfolio

  • Abbott operates across medical devices, diagnostics, nutrition and established pharmaceuticals.
  • The portfolio spans cardiovascular care, diabetes monitoring and laboratory testing.
Abbott Laboratories, US0028241000, Illustration mit AI erstellt.

Abbott Laboratories stock traded at 95.30 euros on Lang & Schwarz at 08:24 CET on Wednesday, November 18, 2026, 1.02 percent below the Xetra close of Tuesday, November 17, 2026.

Abbott develops healthcare products across medical devices, diagnostics, nutrition and established pharmaceuticals. The diversified portfolio spans cardiovascular care, diabetes monitoring and laboratory testing, giving the group several operating growth drivers.

Zacks Equity Research described Abbott's portfolio as broad-based in a November 13 review of the company's third-quarter performance. The report highlighted medical devices, diagnostics, nutrition and established pharmaceuticals as key businesses.

The broader market backdrop is tracked by the S&P 500.

More news and analyses on Abbott Laboratories stock

Disclaimer...
en | US0028241000 | ABBOTT LABORATORIES | boerse | 70529956 | bgmi